| Literature DB >> 26561285 |
Masayoshi Arai1, Takashi Kawachi2, Naoyuki Kotoku2, Chiaki Nakata2, Haruhiko Kamada2,3, Shin-ichi Tsunoda2,3, Yasuo Tsutsumi2,3, Hiroko Endo4, Masahiro Inoue2,4, Hiroki Sato2, Motomasa Kobayashi5.
Abstract
Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. Cancer research has therefore focused on the identification of molecules responsible for hypoxia adaptation in cancer cells, as well as the development of new compounds with action against hypoxia-adapted cancer cells. The marine natural product furospinosulin-1 (1) has displayed hypoxia-selective growth inhibition against cultured cancer cells, and has shown in vivo anti-tumor activity, although its precise mode of action and molecular targets remain unclear. In this study, we found that 1 is selectively effective against hypoxic regions of tumors, and that it directly binds to the transcriptional regulators p54(nrb) and LEDGF/p75, which have not been previously identified as mediators of hypoxia adaptation in cancer cells.Entities:
Keywords: anticancer agents; binding protein; cancer; furospinosulin-1; hypoxia; natural products
Mesh:
Substances:
Year: 2015 PMID: 26561285 DOI: 10.1002/cbic.201500519
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164